CD4 and neoplasm: CD4+ T-cell subsets can exert both anti-tumor and pro-tumor effects: Th1 cells enhance cytotoxic immunity and are generally associated with favorable outcomes, whereas Th17 cells and regulatory T-cells may promote inflammation-driven tumor progression or suppress effective anti-tumor responses.